This week, we feature a special guest podcast speaker - Scott Dorfman, chief executive officer of non-profit gene therapy developer Odylia Therapeutics on his personal journey and the future in gene therapy development.
If you would like to know more about Odylia Therapeutics, please visit https://odylia.org/
Presenter: Aparna Krishnan
Contributor: Scott Dorfman, CEO, Odylia Therapeutics
Producer: Aparna Krishnan
